<http://webisa.webdatacommons.org/380610498>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/prov/516242112>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/380610498> .
<http://webisa.webdatacommons.org/380610498>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/380610498>	<http://www.w3.org/ns/prov#value>	"a) providing a linear peptide having the first sequence Boc-D-Phe-Cys(Trt)-Phe-D-Trp-Lys(Boc)-Thr(tBu)-Cys(Trt)-2Cl-trityl-R, wherein R is a polymer insoluble in dichloromethane or dimethylformamide; b) treating the first sequence with an acid to obtain Boc-D-Phe-Cys(Trt)-Phe-D-Trp-Lys(Boc)-Thr(tBu)-Cys(Trt)OH; c) obtaining (2,7 cyclic) Boc-D-Phe-Cys(Trt)-Phe-D-Trp-Lys(Boc)-Thr(tBu)-Cys(Trt)-Throl" .